{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,19]],"date-time":"2026-09-19T11:14:14Z","timestamp":1789816454405,"version":"4.0.1"},"reference-count":36,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2012,7,1]],"date-time":"2012-07-01T00:00:00Z","timestamp":1341100800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of Hepatology"],"published-print":{"date-parts":[[2012,7]]},"DOI":"10.1016\/j.jhep.2012.02.014","type":"journal-article","created":{"date-parts":[[2012,3,10]],"date-time":"2012-03-10T18:15:43Z","timestamp":1331403343000},"page":"133-140","source":"Crossref","is-referenced-by-count":106,"title":["Effect of ursodeoxycholic acid on bile acid profiles and intestinal detoxification machinery in primary biliary cirrhosis and health"],"prefix":"10.1016","volume":"57","author":[{"given":"Karin","family":"Dilger","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simon","family":"Hohenester","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ursula","family":"Winkler-Budenhofer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barbara A.J.","family":"Bastiaansen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frank G.","family":"Schaap","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian","family":"Rust","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ulrich","family":"Beuers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jhep.2012.02.014_b0005","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/j.jhep.2009.04.009","article-title":"Management of cholestatic liver diseases","volume":"51","year":"2009","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2012.02.014_b0010","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1002\/hep.22906","article-title":"Primary biliary cirrhosis","volume":"50","author":"Lindor","year":"2009","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2012.02.014_b0015","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1002\/hep.22428","article-title":"Biochemical response to ursodeoxycholic acid and long-term prognosis in primary biliary cirrhosis","volume":"48","author":"Corpechot","year":"2008","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2012.02.014_b0020","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.1053\/j.gastro.2009.01.003","article-title":"Improved prognosis of patients with primary biliary cirrhosis that have a biochemical response to ursodeoxycholic acid","volume":"136","author":"Kuiper","year":"2009","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhep.2012.02.014_b0025","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1053\/j.gastro.2005.12.029","article-title":"Excellent long-term survival in patients with primary biliary cirrhosis and biochemical response to ursodeoxycholic acid","volume":"130","author":"Pares","year":"2006","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhep.2012.02.014_b0030","doi-asserted-by":"crossref","first-page":"2186","DOI":"10.1038\/ajg.2010.216","article-title":"Baseline ductopenia and treatment response predict long-term histological progression in primary biliary cirrhosis","volume":"105","author":"Kumagi","year":"2010","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.jhep.2012.02.014_b0035","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1038\/ncpgasthep0521","article-title":"Drug insight: mechanisms and sites of action of ursodeoxycholic acid in cholestasis","volume":"3","author":"Beuers","year":"2006","journal-title":"Nat Clin Pract Gastroenterol Hepatol"},{"key":"10.1016\/j.jhep.2012.02.014_b0040","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1053\/jhep.2002.36088","article-title":"Ursodeoxycholic acid in cholestatic liver disease: mechanisms of action and therapeutic use revisited","volume":"36","author":"Paumgartner","year":"2002","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2012.02.014_b0045","doi-asserted-by":"crossref","first-page":"1498","DOI":"10.1111\/j.1572-0241.1998.00470.x","article-title":"Relationship between biliary and serum bile acids and response to ursodeoxycholic acid in patients with primary biliary cirrhosis","volume":"93","author":"Lindor","year":"1998","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.jhep.2012.02.014_b0050","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.1002\/hep.1840140609","article-title":"Changes in bile acid composition in patients with primary biliary cirrhosis induced by ursodeoxycholic acid administration","volume":"14","author":"Crosignani","year":"1991","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2012.02.014_b0055","first-page":"691","article-title":"Effect of long-term treatment with ursodiol on clinical and biochemical features and biliary bile acid metabolism in patients with primary biliary cirrhosis","volume":"88","author":"Batta","year":"1993","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.jhep.2012.02.014_b0060","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1016\/S1590-8658(02)80112-8","article-title":"Improved liver test and greater biliary enrichment with high dose ursodeoxycholic acid in early stage primary biliary cirrhosis","volume":"34","author":"Roda","year":"2002","journal-title":"Dig Liver Dis"},{"key":"10.1016\/j.jhep.2012.02.014_b0065","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1053\/jhep.2003.50311","article-title":"Ursodeoxycholic acid therapy and the risk of colorectal adenoma in patients with primary biliary cirrhosis: an observational study","volume":"38","author":"Serfaty","year":"2003","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2012.02.014_b0070","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1053\/gast.2003.50156","article-title":"Ursodeoxycholic acid as a chemopreventive agent in patients with ulcerative colitis and primary sclerosing cholangitis","volume":"124","author":"Pardi","year":"2003","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhep.2012.02.014_b0075","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1111\/j.1365-2036.2005.02650.x","article-title":"The impact of ursodeoxycholic acid on cancer, dysplasia and mortality in ulcerative colitis patients with primary sclerosing cholangitis","volume":"22","author":"Wolf","year":"2005","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.jhep.2012.02.014_b0080","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1136\/gut.2005.067389","article-title":"Adaptive regulation of the ileal apical sodium dependent bile acid transporter (ASBT) in patients with obstructive cholestasis","volume":"55","author":"Hruz","year":"2006","journal-title":"Gut"},{"key":"10.1016\/j.jhep.2012.02.014_b0085","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1111\/j.1476-5381.2008.00030.x","article-title":"Nuclear receptors as therapeutic targets in cholestatic liver diseases","volume":"156","author":"Zollner","year":"2009","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.jhep.2012.02.014_b0090","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1007\/s12016-008-8085-y","article-title":"Medical treatment of primary sclerosing cholangitis: a role for novel bile acids and other (post-) transcriptional modulators?","volume":"36","author":"Beuers","year":"2009","journal-title":"Clin Rev Allergy Immunol"},{"key":"10.1016\/j.jhep.2012.02.014_b0095","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1016\/j.gastro.2005.05.009","article-title":"Complementary stimulation of hepatobiliary transport and detoxification systems by rifampicin and ursodeoxycholic acid in humans","volume":"129","author":"Marschall","year":"2005","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhep.2012.02.014_b0100","unstructured":"Guidance for Industry. Bioanalytical method validation. Food and Drug Administration. Available from: http:\/\/www.fda.gov\/cder\/guidance\/4252fnl.pdf."},{"key":"10.1016\/j.jhep.2012.02.014_b0105","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1046\/j.1365-2036.1998.00395.x","article-title":"A randomized trial in primary biliary cirrhosis comparing ursodeoxycholic acid in daily doses of either 10mg\/kg or 20mg\/kg. Dutch Multicentre PBC Study Group","volume":"12","author":"Van Hoogstraten","year":"1998","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.jhep.2012.02.014_b0110","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1136\/gut.13.3.201","article-title":"Serum bile acids in primary biliary cirrhosis","volume":"13","author":"Murphy","year":"1972","journal-title":"Gut"},{"key":"10.1016\/j.jhep.2012.02.014_b0115","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1002\/hep.510250104","article-title":"Decreased anion exchanger 2 immunoreactivity in the liver of patients with primary biliary cirrhosis","volume":"25","author":"Medina","year":"1997","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2012.02.014_b0120","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/S0016-5085(99)70564-0","article-title":"Assessment of biliary bicarbonate secretion in humans by positron emission tomography","volume":"117","author":"Prieto","year":"1999","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhep.2012.02.014_b0125","doi-asserted-by":"crossref","first-page":"1489","DOI":"10.1002\/hep.23810","article-title":"The biliary HCO(3)(\u2212) umbrella: a unifying hypothesis on pathogenetic and therapeutic aspects of fibrosing cholangiopathies","volume":"52","author":"Beuers","year":"2010","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2012.02.014_b0130","doi-asserted-by":"crossref","first-page":"20210","DOI":"10.1074\/jbc.M909992199","article-title":"The bile acid taurochenodeoxycholate activates a phosphatidylinositol 3-kinase-dependent survival signaling cascade","volume":"275","author":"Rust","year":"2000","journal-title":"J Biol Chem"},{"key":"10.1016\/j.jhep.2012.02.014_b0135","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1016\/j.jhep.2010.05.015","article-title":"Phosphatidylinositol-3-kinase p110gamma contributes to bile salt-induced apoptosis in primary rat hepatocytes and human hepatoma cells","volume":"53","author":"Hohenester","year":"2010","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2012.02.014_b0140","doi-asserted-by":"crossref","first-page":"2908","DOI":"10.1074\/jbc.M804585200","article-title":"Bile acid-induced apoptosis in hepatocytes is caspase-6-dependent","volume":"284","author":"Rust","year":"2009","journal-title":"J Biol Chem"},{"key":"10.1016\/j.jhep.2012.02.014_b0145","doi-asserted-by":"crossref","first-page":"S280","DOI":"10.1016\/S0168-8278(11)60700-9","article-title":"Differential induction of mitochondrial failure by bile acids in a direct and Ca-independent fashion [abstract]","volume":"54","author":"Schulz","year":"2011","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2012.02.014_b0150","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1002\/hep.24691","article-title":"A biliary HCO(3)(\u2212) umbrella constitutes a protective mechanism against bile acid-induced injury in human cholangiocytes","volume":"55","author":"Hohenester","year":"2012","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2012.02.014_b0155","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1002\/hep.20568","article-title":"No relevant effect of ursodeoxycholic acid on cytochrome P450 3A metabolism in primary biliary cirrhosis","volume":"41","author":"Dilger","year":"2005","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2012.02.014_b0160","doi-asserted-by":"crossref","first-page":"159","DOI":"10.2165\/00003088-200140030-00002","article-title":"The gut as a barrier to drug absorption: combined role of cytochrome P450 3A and P-glycoprotein","volume":"40","author":"Zhang","year":"2001","journal-title":"Clin Pharmacokinet"},{"key":"10.1016\/j.jhep.2012.02.014_b0165","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1016\/j.clpt.2006.01.005","article-title":"Effects of ursodeoxycholic acid on P-glycoprotein and cytochrome P450 3A4-dependent pharmacokinetics in humans","volume":"79","author":"Becquemont","year":"2006","journal-title":"Clin Pharmacol Ther"},{"key":"10.1016\/j.jhep.2012.02.014_b0170","doi-asserted-by":"crossref","first-page":"603","DOI":"10.2174\/138920010792927325","article-title":"Structure and function of the human breast cancer resistance protein (BCRP\/ABCG2)","volume":"11","author":"Ni","year":"2010","journal-title":"Curr Drug Metab"},{"key":"10.1016\/j.jhep.2012.02.014_b0175","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/S0022-3565(24)29314-9","article-title":"Correlation of gene expression of ten drug efflux proteins of the ATP-binding cassette transporter family in normal human jejunum and in human intestinal epithelial Caco-2 cell monolayers","volume":"299","author":"Taipalensuu","year":"2001","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.jhep.2012.02.014_b0180","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1007\/s00424-006-0109-y","article-title":"The apical conjugate efflux pump ABCC2 (MRP2)","volume":"453","author":"Nies","year":"2007","journal-title":"Pflugers Arch"}],"updated-by":[{"DOI":"10.1016\/j.jhep.2013.11.027","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2014,3,1]],"date-time":"2014-03-01T00:00:00Z","timestamp":1393632000000}}],"container-title":["Journal of Hepatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168827812002012?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168827812002012?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,3,22]],"date-time":"2025-03-22T23:13:52Z","timestamp":1742685232000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0168827812002012"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,7]]},"references-count":36,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2012,7]]}},"alternative-id":["S0168827812002012"],"URL":"https:\/\/doi.org\/10.1016\/j.jhep.2012.02.014","relation":{},"ISSN":["0168-8278"],"issn-type":[{"value":"0168-8278","type":"print"}],"subject":[],"published":{"date-parts":[[2012,7]]}}}